2020年webPOISONCONTROL数据总结
本研究分析2020年webPOISONCONTROL所有完成的、非重复的公众病例数据,使用定制Qlik Sense仪表盘进行统计。156,202例中52.9%为4岁以下儿童,69.8%初始分诊至家庭,28.4%建议致电毒物控制中心,1.7%转诊急诊;家庭分诊病例随访率33.3%,其中1.7%分诊建议发生改变。药物涉及41.5%,一次性双倍剂量治疗错误17,901例(占药物病例27.6%);褪黑素为最常见通用物质(4.5%)。72.0%病例无效应、轻微效应或未知结局但毒性轻微,无死亡,17例主要结局(0.01%),26.7%为潜在毒性暴露但未确定结局。2020年webPOISONCONTROL处理的人体毒物暴露病例数为美国电话毒物控制中心报告的7.3%,在线病例更偏向年轻年龄(4岁以下53% vs 电话37%)和非药物(58.5% vs 43.5%);近实时数据可视化检测到COVID-19相关的手消毒剂和清洁剂暴露增加,显示其公共卫生监测和危害检测能力。
要点
- 2020年webPOISONCONTROL共156,202例,52.9%为4岁以下儿童,69.8%初始分诊至家庭,1.7%转诊急诊。
- 家庭分诊病例随访率33.3%,其中1.7%分诊建议发生改变;无死亡,17例主要结局(0.01%)。
- 药物涉及41.5%,一次性双倍剂量治疗错误17,901例(占药物病例27.6%);褪黑素为最常见通用物质(4.5%)。
- 在线病例较电话毒物中心更偏向4岁以下儿童(53% vs 37%)和非药物(58.5% vs 43.5%)。
- 近实时数据可视化检测到COVID-19相关手消毒剂和清洁剂暴露增加,显示公共卫生监测和危害检测能力。
适用人群与场景
- 2020年所有完成、非重复的webPOISONCONTROL公众病例,共156,202例,52.9%为4岁以下儿童。
处置流程与药物剂量
- 初始分诊:109,057例(69.8%)分诊至家庭,28.4%建议致电毒物控制中心,1.7%转诊急诊。
- 家庭分诊病例随访率33.3%,其中1.7%分诊建议发生改变。
研究设计与关键结果
- 研究类型为2020年webPOISONCONTROL病例数据分析,使用定制Qlik Sense仪表盘,共156,202例。
- 52.9%为4岁以下儿童;药物涉及41.5%,非药物58.5%;摄入途径最常见(88.4%,138,012例)。
- 一次性双倍剂量治疗错误17,901例(占药物病例27.6%);化妆品(13.9%)和清洁物质(12.9%)为最常见物质类别;褪黑素为最常见通用物质(4.5%)。
- 72.0%病例无效应(21.4%)、轻微效应(3.9%)或毒性轻微但结局未知(46.7%);无死亡,17例主要结局(0.01%),26.7%为潜在毒性暴露但未确定结局。
- 2020年webPOISONCONTROL处理的人体毒物暴露病例数为美国电话毒物控制中心报告的7.3%;在线病例4岁以下占53% vs 电话37%,非药物占58.5% vs 43.5%。
- 近实时数据可视化检测到COVID-19相关手消毒剂和清洁剂暴露增加。
证据类型、等级与局限
- 证据类型:基于webPOISONCONTROL 2020年病例数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为webPOISONCONTROL工具为无法或不愿使用电话致电传统毒物中心的人提供安全、快速且全自动的替代方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Increasing use of the internet for health information has decreased utilization of traditional telephone-based poison centers in the United States. webPOISONCONTROL®, a browser-based tool and app was launched to meet the growing demand for online, personalized recommendations for human poison exposures. This study was conducted to characterize webPOISONCONTROL cases and highlight its potential for real-time monitoring of poisoning.
METHODS: Case data for all completed, nonduplicated public cases entered in 2020 were analyzed using a custom Qlik Sense dashboard.
RESULTS: Of the 156,202 cases, 52.9% occurred in children younger than 4 years. Most cases (109,057, 69.8%) were initially triaged to home, 28.4% were advised to call Poison Control, and 1.7% were referred to the ED. Follow-up was available for 33.3% of home-triaged cases; 1.7% of those had a change in triage recommendation. Pharmaceuticals were implicated in 41.5% of cases (nonpharmaceuticals in 58.5%). Ingestion was the most common route (88.4%, 138,012). One-time double dose therapeutic error cases were implicated in 17,901 cases (27.6% of pharmaceutical cases). Cosmetics (13.9%) and cleaning substances (12.9%) were the most frequent substance categories. Melatonin was the most frequently implicated generic substance (4.5% of cases). Most (72.0%) cases had no effect (21.4%), a minor effect (3.9%) or were minimally toxic with unknown outcome (46.7%). There were no deaths, 17 major outcomes (0.01%), and 26.7% of cases had potentially toxic exposures with no outcome determination. In 2020, webPOISONCONTROL handled 7.3% as many human poison exposure cases as were reported to U.S. phone-based poison centers. Online cases are skewed towards younger ages (53% in children younger than 4 years vs 37% of phone-based cases) and towards nonpharmaceuticals (58.5% vs 43.5%). Near real-time data visualizations enabled detection of COVID-19-related increases in exposures to hand sanitizers and cleaners, illustrating the public health surveillance and hazard detection capabilities of webPOISONCONTROL.
CONCLUSION: The webPOISONCONTROL tool provides a safe, quick and fully-automated alternative to those who are unable or unwilling to use the telephone to call a traditional poison center.
参考来源
- Reid NE, Johnson-Arbor K, Smolinske S, et al. 2020 webPOISONCONTROL data summary. Am J Emerg Med. 2022. PMID: 35158261. doi:10.1016/j.ajem.2022.02.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。